-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
R&D base
22
2024-09
As a pioneer in digital and intelligent pharmaceuticals, Keyuan Pharmaceutical has consistently embraced lean manufacturing as one of the core principles driving its business growth. Since March, the company has established a Lean Promotion Committee, leveraging initiatives such as fostering lean awareness across the organization and implementing advanced tools like digital and intelligent lean value-stream analysis. As a result, the company has achieved remarkable improvements at its benchmark factory.
2024-09-22
08
2024-09
At 30, we stand firm with vibrant energy, steadily moving forward with practical action toward the future! On September 28, Linuo Group celebrated a significant milestone in its remarkable journey—its 30th anniversary.
2024-09-08
02
2024-09
Recently, the China United Nations Procurement Promotion Association released the group standard T/UNP 178—2024, "Guidelines for Digital Transformation in Pharmaceutical Companies," marking a significant step forward for China's pharmaceutical enterprises in their digital transformation journey.
2024-09-02
27
2024-08
To accelerate the entry of several company products into international markets and further enhance the competitive edge of "industrial globalization," Keyuan Pharmaceutical (stock code: 301281.SZ) recently held a special international registration conference. Senior management, the R&D team, and international registration experts gathered together to jointly discuss and map out implementation strategies for the international registration of multiple company products, providing robust product support to continuously boost Keyuan Pharmaceutical's export revenue.
2024-08-27
23
2024-08
Recently, Keyuan Pharmaceutical (stock code: 301281.SZ) successfully held a unique Internship Report Meeting for Management Trainees, accompanied by a mentorship agreement signing ceremony. This event not only highlighted Keyuan Pharmaceutical's strong commitment to talent development but also underscored the company's deep appreciation for the time-honored practices of mentorship and the enduring legacy of craftsmanship.
2024-08-23
21
2024-08
To achieve the long-term goal of enhancing quality, reducing costs, and boosting efficiency, Keyuan Pharmaceutical (stock code: 301281.SZ) has established a Lean Digital Intelligence Center, aiming to build a benchmark factory and develop a highly efficient and stable lean digital production system. This initiative has also enabled the company to cultivate a lean management team that is highly aware, well-experienced, and professionally proficient, yielding remarkable phased achievements thus far.
2024-08-21
16
2024-08
The place where dreams set sail | Keyuan, I want to say to you!
The place where dreams set sail
2024-08-16
09
2024-08
Lean production starts with strong management. Since March, Keyuan Pharmaceutical (stock code: 301281.SZ) has established a Lean Promotion Committee to foster a company-wide lean mindset. Under the guidance of the group’s lean experts, the company has successfully implemented the principles of digital and intelligent lean manufacturing, introducing cutting-edge tools such as digital-empowered lean value-stream analysis. As a result, the benchmark factory has achieved remarkable improvements, marking a solid step forward on the journey toward enhancing quality, reducing costs, and boosting efficiency across the enterprise.
2024-08-09
05
2024-08
Recently, the international marketing team of Keyuan Pharmaceutical successfully concluded its exchange and research activities in the Southeast Asian market. Led by Chairman and President Jiang Hongsheng and Director of International Trade Shi Bin, the initiative included visits to existing clients, development of new business relationships, and exploration of market opportunities. These efforts not only deepened Keyuan Pharmaceutical's understanding and communication with the Southeast Asian market but also laid a solid foundation for the company to further expand its international operations.
2024-08-05
03
2024-08
Recently, the 2024 Active Pharmaceutical Ingredient Continuous Manufacturing Technology Exchange Conference was successfully held in Dunhua City, Jilin Province. The event brought together extensive industry expertise and collaborative efforts, fostering discussions on the latest advancements, key technological trends, and future prospects of continuous manufacturing, while also paving the way for partnerships and joint growth initiatives.
2024-08-03
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline